For: | Ibrahim SM, Lewandowski RJ, Sato KT, Gates VL, Kulik L, Mulcahy MF, Ryu RK, Omary RA, Salem R. Radioembolization for the treatment of unresectable hepatocellular carcinoma: A clinical review. World J Gastroenterol 2008; 14(11): 1664-1669 [PMID: 18350597 DOI: 10.3748/wjg.14.1664] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i11/1664.htm |
Number | Citing Articles |
1 |
Suresh Subramanian, K.V. Vimalnath, Ashutosh Dash. Preparation and preliminary in vivo evaluation of 166Ho‐labeled microspheres for possible use in radioembolic therapy of liver cancer. Journal of Labelled Compounds and Radiopharmaceuticals 2018; 61(6): 509 doi: 10.1002/jlcr.3616
|
2 |
Xiao-Dong Wang, Ren-Jie Yang, Xi-Cai Cao, Jian Tan, Bin Li. Dose Delivery Estimated by Bremsstrahlung Imaging and Partition Model Correlated with Response Following Intra-arterial Radioembolization with 32P-Glass Microspheres for the Treatment of Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery 2010; 14(5): 858 doi: 10.1007/s11605-010-1180-4
|
3 |
Judith Meza-Junco, Aldo J. Montano-Loza, David M. Liu, Michael B. Sawyer, Vincent G. Bain, Mang Ma, Richard Owen. Locoregional radiological treatment for hepatocellular carcinoma; Which, when and how?. Cancer Treatment Reviews 2012; 38(1): 54 doi: 10.1016/j.ctrv.2011.05.002
|
4 |
Charles H. Cha, M. Wasif Saif, Brett H. Yamane, Sharon M. Weber. Hepatocellular Carcinoma: Current Management. Current Problems in Surgery 2010; 47(1): 10 doi: 10.1067/j.cpsurg.2009.09.003
|
5 |
Amit Singal, Jorge A. Marrero. Yamada' s Textbook of Gastroenterology. 2015; : 2146 doi: 10.1002/9781118512074.ch109
|
6 |
Nicholas Voutsinas, Safet Lekperic, Sharon Barazani, Joseph J. Titano, Sherif I. Heiba, Edward Kim. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques. Journal of Nuclear Medicine 2018; 59(11): 1649 doi: 10.2967/jnumed.116.186346
|
7 |
J. Arias Fernández, B. Martín Martín, N. Pinheiro da Silva, M.L. Díaz, J.I. Bilbao. Vasos extrahepáticos dependientes de la arteria hepática. Identificación y manejo. Radiología 2011; 53(1): 18 doi: 10.1016/j.rx.2010.07.007
|
8 |
Yu Ma, Bo Li, Lin Li, Li-Geng Duan, Yong-Gang Wei, Xiao-Li Chen. In Vivo Distribution of 131I and 125I Dual-Labeled Gelatin Microspheres After Implantation into Rabbit Liver. Cancer Biotherapy and Radiopharmaceuticals 2012; 27(4): 267 doi: 10.1089/cbr.2011.1156
|
9 |
Tushar Garg, Apurva Shrigiriwar, Peiman Habibollahi, Mircea Cristescu, Robert P. Liddell, Julius Chapiro, Peter Inglis, Juan C. Camacho, Nariman Nezami. Intraarterial Therapies for the Management of Hepatocellular Carcinoma. Cancers 2022; 14(14): 3351 doi: 10.3390/cancers14143351
|
10 |
Shumei Ma, Benzheng Jiao, Xin Liu, Heqing Yi, Dejuan Kong, Lin Gao, Guangtong Zhao, Yu Yang, Xiaodong Liu. Approach to radiation therapy in hepatocellular carcinoma. Cancer Treatment Reviews 2010; 36(2): 157 doi: 10.1016/j.ctrv.2009.11.008
|
11 |
Jing-Yue Yang, Da-Yong Cao, Yan Xue, Zhao-Cai Yu, Wen-Chao Liu. Improvement of dendritic-based vaccine efficacy against hepatitis B virus–related hepatocellular carcinoma by two tumor-associated antigen gene–infected dendritic cells. Human Immunology 2010; 71(3): 255 doi: 10.1016/j.humimm.2009.12.010
|
12 |
Tatulya Tiwari, Christopher Malone, Gretchen Foltz, Olaguoke Akinwande, Raja S. Ramaswamy. Yttrium-90 Radioembolization: Current Clinical Practice and Review of the Recent Literature. Journal of Radiology Nursing 2019; 38(2): 86 doi: 10.1016/j.jradnu.2019.03.004
|
13 |
J. Michael Mathis, Shilpa Bhatia, Alok Khandelwal, Imre Kovesdi, Stephen J. Lokitz, Yoshi Odaka, Amol M. Takalkar, Tracee Terry, David T. Curiel, Maciej Lesniak. Genetic Incorporation of Human Metallothionein into the Adenovirus Protein IX for Non-Invasive SPECT Imaging. PLoS ONE 2011; 6(2): e16792 doi: 10.1371/journal.pone.0016792
|
14 |
Erik N. K. Cressman, Matthew G. Geeslin, Mithun M. Shenoi, Leah J. Hennings, Yan Zhang, Paul A. Iaizzo, John C. Bischof. Concentration and volume effects in thermochemical ablation in vivo: Results in a porcine model. International Journal of Hyperthermia 2012; 28(2): 113 doi: 10.3109/02656736.2011.644621
|
15 |
Kevin Ka Wan Chu, Tan To Cheung. Update in management of hepatocellular carcinoma in Eastern population. World Journal of Hepatology 2015; 7(11): 1562-1571 doi: 10.4254/wjh.v7.i11.1562
|
16 |
J.J. Cuaron, J.A. Hirsch, D.C. Medich, B.S. Rosenstein, C.B. Martel, A.E. Hirsch. A Proposed Methodology to Select Radioisotopes for Use in Radionuclide Therapy. American Journal of Neuroradiology 2009; 30(10): 1824 doi: 10.3174/ajnr.A1773
|
17 |
Chuan-Chao Li, Jun-Lin Chi, Yu Ma, Jian-Hong Li, Chuan-Qin Xia, Lin Li, Zhuo Chen, Xiao-Li Chen. Interventional therapy for human breast cancer in nude mice with 131I gelatin microspheres (131I-GMSs) following intratumoral injection. Radiation Oncology 2014; 9(1) doi: 10.1186/1748-717X-9-144
|
18 |
|
19 |
|
20 |
Archana Mukherjee, Suresh Subramanian, Rajwardhan Ambade, Bhaurao Avhad, Ashutosh Dash, Aruna Korde. Development of Semiautomated Module for Preparation of 131I Labeled Lipiodol for Liver Cancer Therapy. Cancer Biotherapy and Radiopharmaceuticals 2017; 32(1): 33 doi: 10.1089/cbr.2016.2088
|
21 |
Subhajit Ghosh, Tapas Das, Haladhar D. Sarma, Sharmila Banerjee. Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent. Journal of Radioanalytical and Nuclear Chemistry 2017; 311(1): 263 doi: 10.1007/s10967-016-4985-0
|
22 |
Carlo Spreafico, Carlo Morosi, Marco Maccauro, Raffaele Romito, Rodolfo Lanocita, Enrico M. Civelli, Carlo Sposito, Sherrie Bhoori, Carlo Chiesa, Laura F. Frigerio, Alice Lorenzoni, Tommaso Cascella, Alfonso Marchianò, Vincenzo Mazzaferro. Intrahepatic Flow Redistribution in Patients Treated with Radioembolization. CardioVascular and Interventional Radiology 2015; 38(2): 322 doi: 10.1007/s00270-014-0921-2
|
23 |
Zachary J. Brown, D Brock Hewitt, Timothy M Pawlik. Combination therapies plus transarterial chemoembolization in hepatocellular carcinoma: a snapshot of clinical trial progress. Expert Opinion on Investigational Drugs 2022; 31(4): 379 doi: 10.1080/13543784.2022.2008355
|
24 |
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies. Oncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
|
25 |
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, Daniel A. Anaya, Robert Anders, Chandrakanth Are, Melinda Bachini, Mitesh Borad, Daniel Brown, Adam Burgoyne, Prabhleen Chahal, Daniel T. Chang, Jordan Cloyd, Anne M. Covey, Evan S. Glazer, Lipika Goyal, William G. Hawkins, Renuka Iyer, Rojymon Jacob, R. Kate Kelley, Robin Kim, Matthew Levine, Manisha Palta, James O. Park, Steven Raman, Sanjay Reddy, Vaibhav Sahai, Tracey Schefter, Gagandeep Singh, Stacey Stein, Jean-Nicolas Vauthey, Alan P. Venook, Adam Yopp, Nicole R. McMillian, Cindy Hochstetler, Susan D. Darlow. Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2021; 19(5): 541 doi: 10.6004/jnccn.2021.0022
|
26 |
Steven Naymagon, Richard R. P. Warner, Kalpesh Patel, Noam Harpaz, Josef Machac, Joshua L. Weintraub, Michelle K. Kim. Gastroduodenal Ulceration Associated with Radioembolization for the Treatment of Hepatic Tumors: An Institutional Experience and Review of the Literature. Digestive Diseases and Sciences 2010; 55(9): 2450 doi: 10.1007/s10620-010-1156-y
|
27 |
Paolo Giunchedi, Marcello Maestri, Elisabetta Gavini, Paolo Dionigi, Giovanna Rassu. Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1. Expert Opinion on Drug Delivery 2013; 10(5): 679 doi: 10.1517/17425247.2013.770733
|
28 |
A. El Mekkaoui, Z. Benbrahim, I. Charif, I. Grigoriu, J. -D. Grangé. Traitement d’un carcinome hépatocellulaire avancé associé à une thrombose porte par radioembolisation au microsphères d’Yttrium-90. Journal Africain du Cancer / African Journal of Cancer 2012; 4(1): 37 doi: 10.1007/s12558-012-0203-8
|
29 |
Shi-hua Luo, Song-lin Song, Chuan-sheng Zheng, Wei-yong Li, Yong Wang, Xiang-wen Xia, Gan-sheng Feng. Embolic effects of Bletilla striata microspheres in renal artery and transplanted VX2 liver tumor model in rabbits. Chinese Journal of Integrative Medicine 2019; 25(6): 431 doi: 10.1007/s11655-017-2953-3
|
30 |
Yuri S. Khotimchenko, Elena V. Khozhaenko, Maxim Y. Khotimchenko, Elena A. Kolenchenko, Valeri V. Kovalev. Carrageenans as a New Source of Drugs with Metal Binding Properties. Marine Drugs 2010; 8(4): 1106 doi: 10.3390/md8041106
|
31 |
Jun-Lin Chi, Chuan-Chao Li, Chuan-Qin Xia, Lin Li, Yu Ma, Jian-Hong Li, Zhuo Chen, Xiao-Li Chen. Effect of131I Gelatin Microspheres on Hepatocellular Carcinoma in Nude Mice and its Distribution after Intratumoral Injection. Radiation Research 2014; 181(4): 416 doi: 10.1667/RR13539.1
|
32 |
Licia Uccelli, Micol Pasquali, Alessandra Boschi, Melchiore Giganti, Adriano Duatti. Automated preparation of Re-188 lipiodol for the treatment of hepatocellular carcinoma. Nuclear Medicine and Biology 2011; 38(2): 207 doi: 10.1016/j.nucmedbio.2010.08.011
|
33 |
J.-F. Dufour, I. Bargellini, N. De Maria, P. De Simone, I. Goulis, R.T. Marinho. Intermediate hepatocellular carcinoma: current treatments and future perspectives. Annals of Oncology 2013; 24: 24 doi: 10.1093/annonc/mdt054
|
34 |
Mengchao Wu, Feng Shen, Jiamei Yang, Weiping Zhou, Yiqun Yan, Xiaohui Fu. Primary Liver Cancer. 2012; : 399 doi: 10.1007/978-3-642-28702-2_13
|
35 |
Liat Mlynarsky, Yoram Menachem, Oren Shibolet. Treatment of hepatocellular carcinoma: Steps forward but still a long way to go. World Journal of Hepatology 2015; 7(3): 566-574 doi: 10.4254/wjh.v7.i3.566
|
36 |
Haiwei Zhang, Juan Zhao, Wei Yang, Zheng Li, Li Gong, Yongsheng Li. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2022; 3: 41 doi: 10.1007/16833_2022_96
|
37 |
Riccardo Lencioni, Xiao-Ping Chen, Lucy Dagher, Alan P. Venook. Treatment of Intermediate/Advanced Hepatocellular Carcinoma in the Clinic: How Can Outcomes Be Improved?. The Oncologist 2010; 15(S4): 42 doi: 10.1634/theoncologist.2010-S4-42
|
38 |
Bahareh Farasati Far, Dorsa Rabie, Parisa Hemati, Parastoo Fooladpanjeh, Neda Faal Hamedanchi, Nima Broomand Lomer, Arian Karimi Rouzbahani, Mohammad Reza Naimi-Jamal. Unresectable Hepatocellular Carcinoma: A Review of New Advances with Focus on Targeted Therapy and Immunotherapy. Livers 2023; 3(1): 121 doi: 10.3390/livers3010011
|
39 |
Jorge A. Marrero. Zakim and Boyer's Hepatology. 2012; : 1005 doi: 10.1016/B978-1-4377-0881-3.00057-7
|
40 |
|
41 |
Andrew S. Kennedy, Riad Salem. Radioembolization (Yttrium-90 Microspheres) for Primary and Metastatic Hepatic Malignancies. The Cancer Journal 2010; 16(2): 163 doi: 10.1097/PPO.0b013e3181d7e8cf
|
42 |
Usha Pandey, Suresh Subramanian, Samina Shaikh, Naresh Gamre, Sanjukta Kumar, Ashutosh Dash. Synthesis and Preliminary Biological Evaluation of 177Lu-Labeled Polyhydroxamic Acid Microparticles Toward Therapy of Hepatocellular Carcinoma. Cancer Biotherapy and Radiopharmaceuticals 2019; 34(5): 306 doi: 10.1089/cbr.2018.2747
|
43 |
Riccardo Lencioni. Loco‐regional treatment of hepatocellular carcinoma†. Hepatology 2010; 52(2): 762 doi: 10.1002/hep.23725
|
44 |
A. Sabet, H. Ahmadzadehfar, J. Bruhman, A. Sabet, C. Meyer, J.-C. Wasmuth, C.-C. Pieper, H.-J. Biersack, S. Ezziddin. Survival in patients with hepatocellular carcinoma treated with 90Y-microsphere radioembolization. Nuklearmedizin 2014; 53(02): 39 doi: 10.3413/Nukmed-0622-13-09
|
45 |
Harry Marquis, Juan C. Ocampo Ramos, Lukas M. Carter, Pat Zanzonico, Wesley E. Bolch, Richard Laforest, Adam L. Kesner. MIRD Pamphlet No. 29: MIRDy90—A90Y Research Microsphere Dosimetry Tool. Journal of Nuclear Medicine 2024; 65(5): 794 doi: 10.2967/jnumed.123.266743
|
46 |
Amr Shaaban Hanafy. Efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience. SpringerPlus 2016; 5(1) doi: 10.1186/s40064-016-3376-x
|
47 |
Maarten LJ Smits, Maurice AAJ van den Bosch, Johannes FW Nijsen, Bernard A Zonnenberg. The evolution of radioembolisation. The Lancet Oncology 2012; 13(12): e519 doi: 10.1016/S1470-2045(12)70484-9
|
48 |
Saad M. Ibrahim, Laura Kulik, Talia Baker, Robert K. Ryu, Mary F. Mulcahy, Michael Abecassis, Riad Salem, Robert J. Lewandowski. Treating and Downstaging Hepatocellular Carcinoma in the Caudate Lobe with Yttrium-90 Radioembolization. CardioVascular and Interventional Radiology 2012; 35(5): 1094 doi: 10.1007/s00270-011-0292-x
|
49 |
Satoru Murata, Takahiko Mine, Fumie Sugihara, Daisuke Yasui, Hidenori Yamaguchi, Tatsuo Ueda, Shiro Onozawa, Shin-ichiro Kumita. Interventional treatment for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 2014; 20(37): 13453-13465 doi: 10.3748/wjg.v20.i37.13453
|
50 |
John J. Waddell, Patricia H. Townsend, Zachary S. Collins, Carissa Walter. Liver-Directed Therapy for Metastatic Colon Cancer: Update. Current Colorectal Cancer Reports 2022; 18(1): 18 doi: 10.1007/s11888-022-00474-1
|
51 |
Stephen L. Harris, Joel E. Tepper. Radiation to the liver for hepatic metastases from colorectal cancer: Stereotactic radiotherapy and radioactive microspheres. Current Colorectal Cancer Reports 2009; 5(3): 140 doi: 10.1007/s11888-009-0021-x
|
52 |
Veronica Goffredo, Angelo Paradiso, Girolamo Ranieri, Cosmo Damiano Gadaleta. Yttrium-90 (90Y) in the principal radionuclide therapies: An efficacy correlation between peptide receptor radionuclide therapy, radioimmunotherapy and transarterial radioembolization therapy. Ten years of experience (1999–2009). Critical Reviews in Oncology/Hematology 2011; 80(3): 393 doi: 10.1016/j.critrevonc.2011.01.012
|
53 |
M. Pracht, J. Edeline, L. Lenoir, M. Latournerie, H. Mesbah, O. Audrain, Y. Rolland, B. Clément, J. L. Raoul, E. Garin, E. Boucher. Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results. International Journal of Hepatology 2013; 2013: 1 doi: 10.1155/2013/827649
|
54 |
Ali Habib, Kush Desai, Ryan Hickey, Bartley Thornburg, Robert Lewandowski, Riad Salem. Locoregional Therapy of Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 401 doi: 10.1016/j.cld.2015.01.008
|
55 |
José I. Bilbao, Puy Garrastachu, María J. Herráiz, Macarena Rodríguez, Mercedes Iñarrairaegui, Javier Rodríguez, Carmen Hernández, Antonio Martínez de la Cuesta, Javier Arbizu, Bruno Sangro. Safety and Efficacy Assessment of Flow Redistribution by Occlusion of Intrahepatic Vessels Prior to Radioembolization in the Treatment of Liver Tumors. CardioVascular and Interventional Radiology 2010; 33(3): 523 doi: 10.1007/s00270-009-9717-1
|
56 |
Jose Enriquez, Sanaz Javadi, Ravi Murthy, Joe Ensor, Armeen Mahvash, Mohamed E Abdelsalam, David C Madoff, Michael J Wallace, Rony Avritscher. Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients. Acta Radiologica 2013; 54(7): 790 doi: 10.1177/0284185113481696
|
57 |
Oliver Dudeck, Karsten Bulla, Gero Wieners, Ricarda Ruehl, Gerd Ulrich, Holger Amthauer, Jens Ricke, Maciej Pech. Embolization of the Gastroduodenal Artery Before Selective Internal Radiotherapy: A Prospectively Randomized Trial Comparing Standard Pushable Coils with Fibered Interlock Detachable Coils. CardioVascular and Interventional Radiology 2011; 34(1): 74 doi: 10.1007/s00270-010-9845-7
|
58 |
Federico Aucejo, William D. Carey. Current Clinical Medicine. 2010; : 649 doi: 10.1016/B978-1-4160-6643-9.00098-9
|
59 |
Malcolm H. Squires, David A. Kooby. Surgical Oncology. 2015; : 335 doi: 10.1007/978-1-4939-1423-4_15
|
60 |
Benjamin Wiesinger, Emese Farkas, Rainer Kehlbach, Rüdiger Bantleon, Matthias Werner, Jakub Wiskirchen. Impact of Rhenium-188, Gemcitabine, and 5-Fluorouracil on Cholangiocellular Carcinoma Cells: An In Vitro Study. CardioVascular and Interventional Radiology 2009; 32(4): 737 doi: 10.1007/s00270-009-9563-1
|
61 |
Manli Jiang, F. Scott Nowakowski, Jason Wang, Sherif Heiba, Zhuangyu Zhang, Joshua Weintraub, Edward Kim, Josef Machac. Characterization of Extrahepatic Distribution of Tc-99m Macroaggregated Albumin in Hepatic Perfusion Imaging Studies Prior to Yttrium-90 Microsphere Therapy. Cancer Biotherapy and Radiopharmaceuticals 2011; 26(4): 511 doi: 10.1089/cbr.2010.0944
|
62 |
Brett Yamane, Sharon Weber. Liver-Directed Treatment Modalities for Primary and Secondary Hepatic Tumors. Surgical Clinics of North America 2009; 89(1): 97 doi: 10.1016/j.suc.2008.10.004
|
63 |
Beatrijs A. Seinstra, Otto M. van Delden, Karel J. van Erpecum, Richard van Hillegersberg, Willem P. Th. M. Mali, Maurice A. A. J. van den Bosch. Minimally invasive image-guided therapy for inoperable hepatocellular carcinoma: What is the evidence today?. Insights into Imaging 2010; 1(3): 167 doi: 10.1007/s13244-010-0027-6
|
64 |
Yuan-Yuan Zhang, Harry Hua-Xiang Xia. Novel therapeutic approaches for hepatocellulcar carcinoma: Fact and fiction. World Journal of Gastroenterology 2008; 14(11): 1641-1642 doi: 10.3748/wjg.14.1641
|
65 |
J. Arias Fernández, B. Martín Martín, N. Pinheiro da Silva, M.L. Díaz, J.I. Bilbao. Extrahepatic vessels depending on the hepatic artery. Identification and management. Radiología (English Edition) 2011; 53(1): 18 doi: 10.1016/S2173-5107(11)70002-7
|
66 |
HUI WANG, FANG FENG, XIAO-PING WANG, ROU-SHU WANG, YING WU, MIN-GAO ZHU, HONG ZHANG, ZHI-XIANG ZHUANG. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Molecular Medicine Reports 2016; 13(2): 1077 doi: 10.3892/mmr.2015.4654
|
67 |
Toshihiro Furuta, Eriko Maeda, Hiroyuki Akai, Shouhei Hanaoka, Naoki Yoshioka, Masaaki Akahane, Takeyuki Watadani, Kuni Ohtomo. Hepatic Segments and Vasculature: Projecting CT Anatomy onto Angiograms. RadioGraphics 2009; 29(7): e37 doi: 10.1148/rg.e37
|
68 |
UEG Week 2016 Poster Presentations. United European Gastroenterology Journal 2016; 4(5_suppl): A157 doi: 10.1177/2050640616663689
|
69 |
Saad M. Ibrahim, Paul Nikolaidis, Frank H. Miller, Robert J. Lewandowski, Robert K. Ryu, Kent T. Sato, Sean Senthilnathan, Ahsun Riaz, Laura Kulik, Mary F. Mulcahy, Reed A. Omary, Riad Salem. Radiologic findings following Y90 radioembolization for primary liver malignancies. Abdominal Imaging 2009; 34(5): 566 doi: 10.1007/s00261-008-9454-y
|
70 |
Shuyi Li, Lynsa Nguyen, Hairong Xiong, Meiyao Wang, Tom C.-C. Hu, Jin-Xiong She, Steven M. Serkiz, George G. Wicks, William S. Dynan. Porous-wall hollow glass microspheres as novel potential nanocarriers for biomedical applications. Nanomedicine: Nanotechnology, Biology and Medicine 2010; 6(1): 127 doi: 10.1016/j.nano.2009.06.004
|
71 |
Da-Yong Cao, Jing-Yue Yang, Shu-Qiang Yue, Kai-Shan Tao, Zhen-Shun Song, De-Sheng Wang, Yan-Ling Yang, Ke-Feng Dou. Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma. Cellular Immunology 2009; 259(1): 13 doi: 10.1016/j.cellimm.2009.05.007
|
72 |
Sudhanshu Gogia, Alex S. Befeler. Treating hepatocellular carcinoma without liver transplantation. Current Gastroenterology Reports 2009; 11(1): 69 doi: 10.1007/s11894-009-0011-9
|
73 |
José I. Bilbao, Alba de Martino, Esther de Luis, Lourdes Díaz-Dorronsoro, Alberto Alonso-Burgos, Antonio Martínez de la Cuesta, Bruno Sangro, José A. García de Jalón. Biocompatibility, Inflammatory Response, and Recannalization Characteristics of Nonradioactive Resin Microspheres: Histological Findings. CardioVascular and Interventional Radiology 2009; 32(4): 727 doi: 10.1007/s00270-009-9592-9
|
74 |
Lourens Bester, Peter G Hobbins, Shih‐chang Wang, Riad Salem. Imaging characteristics following 90yttrium microsphere treatment for unresectable liver cancer. Journal of Medical Imaging and Radiation Oncology 2011; 55(2): 111 doi: 10.1111/j.1754-9485.2011.02241.x
|
75 |
Nima Kokabi, Minzhi Xing, Richard Duszak, David H Howard, Kimberly E Applegate, Juan C Camacho, Hyun S Kim. Sociodemographic Impact on Survival in Unresectable Hepatocellular Carcinoma: A Survival Epidemiology and end Results Study. Future Oncology 2016; 12(2): 183 doi: 10.2217/fon.15.242
|